Condition
Prolapse Pelvic
Total Trials
4
Recruiting
3
Active
3
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 4 (1)
Trial Status
Recruiting3
Completed1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07213635Phase 4Completed
Paracervical Injection and Opioid Use After Vaginal Hysterectomy for Prolapse
NCT07413861Not ApplicableRecruitingPrimary
Vaginal Natural Orifice Transluminal Endoscopic (vNOTE) Hysterectomy With Uterosacral Suspension
NCT04560543Not ApplicableRecruitingPrimary
Prophylactic Laparoscopic Suspension After McCall
NCT06430931Not ApplicableRecruiting
Biological OviTex Versus Synthetic Graft in Robotic Prolapse Surgery
Showing all 4 trials